Alex

RxCell Announces $4,600,000 Investment from DMR Global Venture and Regenosis, Plans for Second Raise of $15,000,000 for IND Testing in Q4 2023

SINGAPORE--(BUSINESS WIRE)--RxCell, a pioneering biotech company focusing on cellular therapeutics for age-related diseases, today proudly announces a $4,600,000 investment commitment…

3 years ago

New VicOne Cybersecurity Report Reveals Growing Automotive Data Exploitation, as Industry Examines Cyberattacks and Security Measures

VicOne Automotive Cyberthreat Landscape Report 2023 reveals supply chain as major source of growth in automotive cyberattacks DALLAS & TOKYO--(BUSINESS…

3 years ago

Australia Voice of the Enterprise Security (Cybersecurity) Customer Trends Report 2023 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Voice of the Enterprise Security Customer - Trends in Australia" report has been added to ResearchAndMarkets.com's offering. This…

3 years ago

CIOs and CTOs Across Australia and New Zealand Struggle Balancing IT Modernization Efforts with Business Growth and Profitability, According to New Survey

Majority of surveyed IT leaders running IT modernization programs are over budget and behind schedule, with results showing only “marginal…

3 years ago

Cloudflare Achieves #6 on Fortune Future 50 List 2023 for Long-Term Growth and Business Potential

Fortune identifies Cloudflare among the top 50 global public companies best positioned for long-term revenue growth SAN FRANCISCO--(BUSINESS WIRE)--Cloudflare, Inc.…

3 years ago

Adani Green accomplishes its Construction Financing Framework at USD 3 billion

Raises USD 1.36 bn construction facility in the latest funding from international banks in one of the largest Project Finance…

3 years ago

Global Specimen Retrieval Strategic Research Report 2023 – ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Specimen Retrieval - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. Global Specimen Retrieval Market to…

3 years ago

Corpay Cross-Border Appoints Roy Farah as new SVP Global Payment Solutions

TORONTO--(BUSINESS WIRE)--Corpay1, a FLEETCOR® (NYSE: FLT) brand and global leader in business payments, is pleased to announce that Corpay’s Cross-Border…

3 years ago

AArete Joins Snowflake Partner Network

Consulting firm’s deep expertise in financial services and healthcare helps clients unlock the full potential of their data through Snowflake…

3 years ago

Takeda and The New York Academy of Sciences Announce 2024 Innovators in Science Award Winners

2024 Award Celebrates Outstanding Research in Cancer Immunology Winners Discovered Novel Connections Between the Immune System and Cancer Recipients Each…

3 years ago

Saudi Fund for Development Provides $100 Million Development Loan for the Rogun Hydropower Project

SHAHRINAV, Tajikistan--(BUSINESS WIRE)--The Saudi Fund for Development (SFD) Chief Executive Officer, H.E. Sultan Al-Marshad, signed a new development loan agreement…

3 years ago

LTIMindtree Ranks Second in Overall Customer Satisfaction in Whitelane Research’s 2023 IT Sourcing Study for Germany

Achieves a score of 80%, well above the industry average of 74% MUNICH & MUMBAI, India--(BUSINESS WIRE)--$LTIM #ITSourcingStudy--LTIMindtree [NSE: LTIM,…

3 years ago

Transforming Health in Singapore: CueZen Collaborates with Microsoft in the 6th World Blue Zone

SINGAPORE--(BUSINESS WIRE)--CueZen Inc. and Microsoft are collaborating to empower the citizens of Singapore on their journey to optimal health. CueZen’s…

3 years ago

TreviPay Introduces All-in-One Payments Solution for Accepting Net Terms and Card Payments at Checkout

TreviPay continues to expand loyalty-building technology for all merchants to perfect the payments experience OVERLAND PARK, Kan.--(BUSINESS WIRE)--#B2B--TreviPay, the global…

3 years ago

RIBOMIC Phase I and II Data Published in the Eye: Full TOFU/RAMEN/TEMPURA Trial Results Demonstrate Clinical Proof of Concept of Umedaptanib Pegol in Exudative Age-Related Macular Degeneration (nAMD)

- Intravitreal umedaptanib pegol (an investigational anti-FGF2 aptamer) is safe, well tolerated, and effective in treatment naïve nAMD patients with…

3 years ago